Pia Renaudin
Chief Executive Officer bij SCIBASE HOLDING AB (PUBL)
Vermogen: 211 526 $ op 31-03-2024
Profiel
Pia Renaudin is currently the Chief Executive Officer at SciBase Holding AB and also holds a Director position at Suturion AB.
Prior to her current roles, she served as the Chief Executive Officer at Senzime AB from 2019 to 2023.
Renaudin received an undergraduate degree from INSEAD and an MBA from the University of Gothenburg in 1992.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SENZIME AB
0.36% | 16-03-2023 | 364 800 ( 0.36% ) | 211 526 $ | 31-03-2024 |
Actieve functies van Pia Renaudin
| Bedrijven | Functie | Begin |
|---|---|---|
| SCIBASE HOLDING AB (PUBL) | Chief Executive Officer | 01-10-2023 |
Suturion AB
 Suturion AB Miscellaneous Commercial ServicesCommercial Services Suturion AB develops and sells medical technology and equipment specializing on surgery. Its devices help minimize abdominal wall complications; reduce needle prick injuries; and promotes time efficiency and precision. The company was founded by Gabriel Börner and Mats O Christensson in 2018 and is headquartered in Lund, Sweden. | Director/Board Member | - |
Eerdere bekende functies van Pia Renaudin
| Bedrijven | Functie | Einde |
|---|---|---|
| SENZIME AB | Chief Executive Officer | 03-05-2023 |
Opleiding van Pia Renaudin
| INSEAD | Undergraduate Degree |
| University of Gothenburg | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SENZIME AB | Health Technology |
| SCIBASE HOLDING AB (PUBL) | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Suturion AB
Suturion AB Miscellaneous Commercial ServicesCommercial Services Suturion AB develops and sells medical technology and equipment specializing on surgery. Its devices help minimize abdominal wall complications; reduce needle prick injuries; and promotes time efficiency and precision. The company was founded by Gabriel Börner and Mats O Christensson in 2018 and is headquartered in Lund, Sweden. | Commercial Services |
